Women with luminal A breast cancer subtype do not seem to benefit from adjuvant chemotherapy
Women with luminal A breast cancer subtype do not seem to benefit from adjuvant chemotherapy
Denosumab improves disease-free survival for postmenopausal HR-positive breast cancer
Women with luminal A subtype of breast cancer did not benefit from adjuvant chemotherapy
Pathologic complete response to presurgery chemo improves survival for triple-negative breast cancer
Radiotherapy access in low and middle income countries
Fertility-sparing surgery in early-detected cervical cancer
Combatting the surgical deficit in Sub-Saharan Africa
Finding strength from within in Africa
Tamoxifen adherence in South Africa
Safe, effective, and affordable breast reconstruction in South Africa
What do South African women fear most about breast cancer?
Capacity-building for successful cancer registries in Kenya